Filing Details
- Accession Number:
- 0001209191-16-112923
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-05 16:03:34
- Reporting Period:
- 2016-04-01
- Filing Date:
- 2016-04-05
- Accepted Time:
- 2016-04-05 16:03:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1517022 | Akebia Therapeutics Inc. | AKBA | Pharmaceutical Preparations (2834) | 208756903 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1602396 | R. Nicole Hadas | C/O Akebia Therapeutics, Inc. 245 First Street, Suite 1100 Cambridge MA 02142 | Svp, General Counsel, Sec. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-04-04 | 1,556 | $9.41 | 85,528 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares sold by reporting person to pay taxes in connection with the vesting of restricted stock pursuant to a December 23, 2013 award. Twenty-five percent of the shares vested on December 2, 2014, and the remaining shares vest in equal quarterly installments through December 2, 2017.